These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1394631

  • 1. Central cholinergic agents. III. Synthesis of 2-alkoxy-2,8- diazaspiro[4.5]decane-1,3-diones as muscarinic agonists.
    Ishihara Y, Yukimasa H, Miyamoto M, Goto G.
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1177-85. PubMed ID: 1394631
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 2-(Substituted)amino-2,8-diazaspiro[4,5]decan-1,3-diones as potential muscarinic agonists: synthesis, modeling and binding studies.
    Barlocco D, Fanelli F, Cignarella G, Villa S, Cattabeni F, Balduini W, Cimino M, De Benedetti PG.
    Drug Des Discov; 1996 Oct; 14(2):129-43. PubMed ID: 9010619
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
    Arnt J, Lembøl HL, Meier E, Pedersen H.
    Eur J Pharmacol; 1992 Jul 21; 218(1):159-69. PubMed ID: 1397027
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and structure-activity studies of a series of 1-oxa-2,8-diazaspiro[4.5]decan-3-ones and related compounds as M1 muscarinic agonists.
    Tsukamoto S, Nagaoka H, Igarashi S, Wanibuchi F, Hidaka K, Tamura T.
    Chem Pharm Bull (Tokyo); 1995 Sep 21; 43(9):1523-9. PubMed ID: 7586076
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and structure-activity studies of a series of 1-oxa-8-azaspiro[4.5]decanes as M1 muscarinic agonists.
    Tsukamoto S, Fujii M, Yasunaga T, Matsuda K, Wanibuchi F, Hidaka K, Furuya T, Tamura T.
    Chem Pharm Bull (Tokyo); 1995 May 21; 43(5):842-52. PubMed ID: 7553970
    [Abstract] [Full Text] [Related]

  • 11. Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships.
    Sauerberg P, Kindtler JW, Nielsen L, Sheardown MJ, Honoré T.
    J Med Chem; 1991 Feb 21; 34(2):687-92. PubMed ID: 1995893
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and selective activity of cholinergic agents with rigid skeletons. I.
    Takemura S, Miki Y, Komada F, Takahashi K, Suzuki A.
    Chem Pharm Bull (Tokyo); 1979 Aug 21; 27(8):1893-900. PubMed ID: 540358
    [No Abstract] [Full Text] [Related]

  • 13. Cholinomimetic activities of minaprine.
    Worms P, Kan JP, Steinberg R, Terranova JP, Perio A, Biziere K.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct 21; 340(4):411-8. PubMed ID: 2586634
    [Abstract] [Full Text] [Related]

  • 14. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
    Hargreaves RJ, McKnight AT, Scholey K, Newberry NR, Street LJ, Hutson PH, Semark JE, Harley EA, Patel S, Freedman SB.
    Br J Pharmacol; 1992 Oct 21; 107(2):494-501. PubMed ID: 1422595
    [Abstract] [Full Text] [Related]

  • 15. Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney.
    Eltze M, Ullrich B, Mutschler E, Moser U, Bungardt E, Friebe T, Gubitz C, Tacke R, Lambrecht G.
    Eur J Pharmacol; 1993 Jul 20; 238(2-3):343-55. PubMed ID: 8405103
    [Abstract] [Full Text] [Related]

  • 16. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A, Brandeis R, Karton I, Pittel Z, Gurwitz D, Haring R, Sapir M, Levy A, Heldman E.
    J Pharmacol Exp Ther; 1991 Apr 20; 257(1):392-403. PubMed ID: 2019998
    [Abstract] [Full Text] [Related]

  • 17. Acetylene compounds of potential pharmacological value. XIX. N-(dialkylaminoalkynyl)-substituted succinimides and 2-pyrrolidones as partial cholinergic agonists.
    Svensson U, Dahlbom R.
    Acta Pharm Suec; 1975 Apr 20; 12(3):209-14. PubMed ID: 1163240
    [No Abstract] [Full Text] [Related]

  • 18. A novel class of conformationally restricted heterocyclic muscarinic agonists.
    Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P.
    J Med Chem; 1986 Jun 20; 29(6):1004-9. PubMed ID: 3712371
    [Abstract] [Full Text] [Related]

  • 19. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
    Shannon HE, Hart JC, Bymaster FP, Calligaro DO, DeLapp NW, Mitch CH, Ward JS, Fink-Jensen A, Sauerberg P, Jeppesen L, Sheardown MJ, Swedberg MD.
    J Pharmacol Exp Ther; 1999 Aug 20; 290(2):901-7. PubMed ID: 10411607
    [Abstract] [Full Text] [Related]

  • 20. Muscarinic receptor agonist-mediated modulation of neuronal activity in rat cerebral cortex.
    Lin Y, Phillis JW.
    Eur J Pharmacol; 1991 Jul 23; 200(1):45-52. PubMed ID: 1722754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.